Many people have asked us if Pulsed ElectroMagnetic Field Therapy is safe for animals with cancer. The answer is YES! Assisi Animal Health is a leading innovator in targeted Pulsed ElectroMagnetic Field (tPEMF) for animals, offering a non-invasive, non-pharmacological therapy for treatment of chronic and acute inflammatory conditions of the body.
What are the contraindications for the Assisi Loop?
Unlike diathermy which offers high-frequency electromagnetic currents, tPEMF has no contraindication for the treatment of patients with cancer or for post-cancer surgical healing. To the contrary, much of the human clinical trial work that has been done has been for post-mastectomy reconstruction patients. *
But tPEMF has a pro-angiogenic effect. How is this different from the angiogenesis of tumors?
There is a misconception about angiogenesis and cancer, in part due to the development of 'anti-angiogenic' therapies in oncology. The angiogenic activity is not normal in tumors as the blood vessels, called tortuous vessels, are poorly formed. tPEMF delivered via the Assisi Loop accelerates ongoing anti-inflammatory processes, one outcome of which is the healthy growth of new blood vessels and normal tissue regeneration.
What is the evidence that I can use this safely with cancer patients?
Ivivi Health Sciences, the company that developed the same microcurrent for humans, has tested the technology in a brain cancer model in rats and found no changes relative to tumor growth in treated animals. tPEMF has been used in human clinical trials on patients getting reconstructive surgery post-cancer with no adverse effects of any kind. Additionally, the FDA-clearance for Ivivi's human product does not carry a contraindication for treating cancer sites.
* The only contraindication for Assisi's Loop is that it cannot be used over implanted systems that include leads - most commonly pacemakers, defibrillators and implanted nerve stimulators.
Please add your bio info through your member profile page, or through your dashboard.
Sign up for our newsletter